| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007513941-A |
| titleOfInvention |
Terrain compound having melanin biosynthesis inhibitory activity and method for producing the same |
| abstract |
The present invention relates to a melanin biosynthesis inhibitor containing a terrain compound and a method for producing the terrain compound. The terrain compound can be easily produced through the strain KCTC26245 of the genus Kabipenicillium that inhabits the soil in Korea. ) Promotes the activity and suppresses the expression of MITF (microphthalmia-associated transcription factor) to show a whitening effect. The inhibitory action on melanin biosynthesis is stronger than existing substances and the mechanism of action is different. A synergistic effect can be expected at the time of compounding application, and it can be usefully used as a skin disease treatment agent, skin whitening agent or browning prevention agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012502022-A |
| priorityDate |
2003-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |